Skip to main content
. Author manuscript; available in PMC: 2016 Aug 22.
Published in final edited form as: Cancer Epidemiol. 2015 Jan 16;39(2):150–156. doi: 10.1016/j.canep.2014.12.006

Table 3.

HRs for over-all and cause-specific cancer mortality by ABO blood type.

Cancer site Blood type N Mortality rate (per 100,000 person-years) HRa (95% CI) HRb (95% CI)
Overall O 1608 11.61 1.00 (Reference) 1.00 (Reference)
A 1090 12.53 1.04 (0.96–1.12) 1.04 (0.95–1.13)
B 900 11.39 0.94 (0.87–1.02) 0.96 (0.87–1.05)
AB 205 10.56 0.89 (0.77–1.03) 0.90 (0.77–1.06)
Non-O 2195 11.84 0.98 (0.92–1.05) 0.99 (0.92–1.06)
Oral O 94 0.68 1.00 (Reference) 1.00 (Reference)
A 59 0.68 0.97 (0.70–1.34) 0.82 (0.57–1.18)
B 46 0.58 0.83 (0.58–1.18) 0.87 (0.60–1.26)
AB 8 0.41 0.60 (0.29–1.23) 0.51 (0.22–1.17)
Non-O 113 0.61 0.87 (0.66–1.15) 0.81 (0.60–1.09)
Esophagus O 38 0.27 1.00 (Reference) 1.00 (Reference)
A 24 0.28 0.96 (0.57–1.60) 1.05 (0.60–1.83)
B 19 0.24 0.83 (0.48–1.44) 0.96 (0.53–1.75)
AB 6 0.31 1.09 (0.46–2.57) 1.15 (0.45–2.96)
Non-O 49 0.26 0.92 (0.60–1.40) 1.02 (0.64–1.63)
Lung O 319 2.30 1.00 (Reference) 1.00 (Reference)
A 213 2.45 1.02 (0.86–1.21) 0.95 (0.78–1.15)
B 199 2.52 1.04 (0.87–1.24) 1.05 (0.86–1.27)
AB 46 2.37 1.00 (0.73–1.36) 1.03 (0.73–1.44)
Non-O 458 2.47 1.03 (0.89–1.18) 1.00 (0.85–1.17)
Stomach O 110 0.79 1.00 (Reference) 1.00 (Reference)
A 101 1.16 1.40 (1.07–1.84) 1.38 (1.02–1.86)
B 60 0.76 0.91 (0.67–1.25) 0.79 (0.55–1.14)
AB 9 0.46 0.57 (0.29–1.12) 0.70 (0.35–1.38)
Non-O 170 0.92 1.11 (0.87–1.41) 1.06 (0.81–1.38)
Liverc O 404 2.92 1.00 (Reference) 1.00 (Reference)
A 247 2.84 0.94 (0.80–1.10) 1.00 (0.84–1.20)
B 213 2.69 0.89 (0.75–1.05) 0.91 (0.75–1.09)
AB 48 2.47 0.83 (0.61–1.12) 0.80 (0.56–1.13)
Non-O 508 2.74 0.91 (0.79–1.03) 0.94 (0.81–1.09)
Pancreas O 45 0.33 1.00 (Reference) 1.00 (Reference)
A 43 0.49 1.47 (0.97–2.23) 1.34 (0.83–2.17)
B 40 0.51 1.49 (0.98–2.29) 1.63 (1.02–2.60)
AB 8 0.41 1.24 (0.59–2.64) 1.38 (0.61–3.09)
Non-O 91 0.49 1.46 (1.02–2.08) 1.47 (0.98–2.19)
Rectum O 52 0.38 1.00 (Reference) 1.00 (Reference)
A 46 0.53 1.36 (0.91–2.02) 1.42 (0.91–2.21)
B 41 0.52 1.32 (0.88–1.99) 1.49 (0.94–2.34)
AB 7 0.36 0.94 (0.43–2.07) 1.21 (0.54–2.70)
Non-O 94 0.51 1.30 (0.93–1.82) 1.42 (0.97–2.08)
Colon O 112 0.81 1.00 (Reference) 1.00 (Reference)
A 78 0.90 1.07 (0.80–1.43) 1.22 (0.89–1.69)
B 48 0.61 0.72 (0.51–1.01) 0.79 (0.54–1.16)
AB 15 0.77 0.94 (0.55–1.61) 1.00 (0.55–1.84)
Non-O 141 0.76 0.90 (0.71–1.16) 1.02 (0.77–1.35)
Kidney O 39 0.28 1.00 (Reference) 1.00 (Reference)
A 22 0.25 0.86 (0.51–1.45) 0.95 (0.53–1.71)
B 25 0.32 1.07 (0.65–1.77) 1.05 (0.58–1.89)
AB 7 0.36 1.25 (0.56–2.80) 0.97 (0.34–2.76)
Non-O 54 0.29 0.99 (0.66–1.50) 1.00 (0.62–1.61)
Bladder O 24 0.17 1.00 (Reference) 1.00 (Reference)
A 17 0.20 1.06 (0.57–1.98) 1.17 (0.51–2.67)
B 19 0.24 1.30 (0.71–2.37) 1.30 (0.57–2.97)
AB 3 0.15 0.86 (0.26–2.84) 0.54 (0.07–4.10)
Non-O 39 0.21 1.14 (0.69–1.90) 1.16 (0.58–2.32)
Leukemia O 32 0.23 1.00 (Reference) 1.00 (Reference)
A 17 0.20 0.82 (0.46–1.48) 0.76 (0.39–1.46)
B 14 0.18 0.74 (0.40–1.39) 0.83 (0.43–1.61)
AB 2 0.10 0.44 (0.11–1.84) 0.52 (0.12–2.19)
Non-O 33 0.18 0.75 (0.46–1.22) 0.76 (0.45–1.29)
Breast (female) O 50 0.67 1.00 (Reference) 1.00 (Reference)
A 36 0.77 1.15 (0.75–1.77) 1.05 (0.64–1.71)
B 35 0.83 1.23 (0.80–1.90) 1.06 (0.64–1.75)
AB 7 0.67 1.01 (0.46–2.23) 0.89 (0.35–2.26)
Non-O 78 0.79 1.17 (0.82–1.67) 1.03 (0.69–1.55)
Prostate (male) O 45 0.71 1.00 (Reference) 1.00 (Reference)
A 35 0.87 1.14 (0.73–1.77) 1.11 (0.66–1.84)
B 23 0.62 0.82 (0.50–1.36) 0.76 (0.42–1.37)
AB 5 0.56 0.74 (0.29–1.85) 0.77 (0.27–2.18)
Non-O 63 0.73 0.96 (0.66–1.41) 0.92 (0.59–1.44)
a

Adjusted for age and sex.

b

Adjusted for age, sex, education level, smoking status, alcohol drinking status, physical activity, and BMI. Individuals with missing covariates were excluded from each model.

c

Also adjusted for HBV infection.